Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events
Cardiovascular Therapeutics · 2025
DOI: 10.1155/cdr/1849432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Kandi Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Echocardiography, Transesophageal, Thromboembolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Hospital Development Center, School of Medicine, Shanghai Jiao Tong University, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Background
Left atrial appendage closure (LAAC) prevents arterial thromboembolic events (ATEs) in nonvalvular atrial fibrillation (AF). Spontaneous echo contrast (SEC) is an independent risk factor for left atrial appendage (LAA) thrombosis; however, there is little knowledge about the relationship between preoperative SEC and the increased risk of device‐related thrombosis (DRT) or ATEs in patients with AF who have undergone LAAC.
Methods
This retrospective study focused on patients with nonvalvular AF who successfully underwent LAAC surgery. Transesophageal echocardiography (TEE) was used to assess preoperative LAA status. SEC in LAA Grades 0–2 was defined as LAASEC−, and Grades 3–4 or previously diagnosed LAA thrombus formation as LAASEC+.
Results
A total of 519 AF patients (432 in LAASEC− group and 87 in LAASEC+ group) who underwent LAAC were included. At the 1‐year follow‐up, there was no significant difference in the incidence of DRT (2.5 vs. 3.8%, p = 0.636), ATEs (0.5 vs. 0%, p = 0.525), and all‐cause mortality (2.1% vs. 2.3%, p = 0.899) between the LAASEC− group and the LAASEC+ group. However, the LAASEC+ group had higher proportions of cauliflower‐type LAA and ≥ 3 lobes.
Conclusions
The difference in preoperative LAA thrombosis or LAASEC was not related to the incidence of DRT or ATEs in AF patients within 1 year after LAAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Baoshan District Yanghang Town Community Health Service Center, Shanghai, China.
ORCID-Profile: Kandi Zhang, Qing He, Junfeng Zhang
Förderung
- Shanghai Hospital Development Center
- School of Medicine, Shanghai Jiao Tong University
- Natural Science Foundation of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zhang, K., Yu, H., Lu, Y., Zhang, P., Liu, D., Huang, J., Zhou, J., Yuan, Y., Zhang, Z., Zhang, Q., He, Q., & Zhang, J. (2025). Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/1849432
Vancouver
Zhang K, Yu H, Lu Y, Zhang P, Liu D, Huang J, et al. Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/1849432
BibTeX
@article{Zhang2025,
author = {Zhang, Kandi and Yu, Hanwen and Lu, Yihua and Zhang, Peng and Liu, Dongsheng and Huang, Jianpeng and Zhou, Jing and Yuan, Yiqian and Zhang, Zongqi and Zhang, Qingyong and He, Qing and Zhang, Junfeng},
title = {Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events},
journal = {Cardiovascular Therapeutics},
year = {2025},
doi = {10.1155/cdr/1849432}
}
EUVIMED